{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:19:26Z","timestamp":1777299566409,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4560,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.fertnstert.2009.05.083","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T04:45:24Z","timestamp":1247201124000},"page":"2047-2049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study"],"prefix":"10.1016","volume":"92","author":[{"given":"Molina B.","family":"Dayal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Frankfurter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice","family":"O'Hern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Peak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Gindoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.05.083_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.fertnstert.2005.02.053","article-title":"Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr","volume":"84","author":"Arslan","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0015-0282(16)54666-4","article-title":"Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation","volume":"56","author":"Frydman","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.fertnstert.2006.07.1457","article-title":"Role of gonadotropin-releasing hormone antagonists in poor responders","volume":"87","author":"Mahutte","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-001-0267-2","article-title":"Use of GnRH antagonists in ovarian stimulation for ART compared with the long protocol: a meta-analysis","volume":"265","author":"Ludwig","year":"2001","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/humrep\/deh334","article-title":"The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF\/ICSI","volume":"19","author":"Mochtar","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib7","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/j.fertnstert.2004.07.616","article-title":"Optimizing GnRH antagonist administration: a meta-analysis of fixed vs flexible protocol","volume":"82","author":"Al-Inany","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib8","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/humrep\/17.11.2842","article-title":"Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective randomized study","volume":"17","author":"Ludwig","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0015-0282(02)04920-8","article-title":"Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy","volume":"79","author":"Kolibianakis","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.fertnstert.2003.07.027","article-title":"Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients","volume":"81","author":"Escudero","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.05.083_bib11","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/humrep\/deg407","article-title":"GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles","volume":"18","author":"Lindheim","year":"2003","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209012217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209012217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:30:45Z","timestamp":1777296645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209012217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0015028209012217"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.05.083","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.05.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}